Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...
This project is an effort to improve the firmware of the Radtel RT-890 in terms of features and radio performance. It is based on DualTachyon's OEFW which is reversed from the original Radtel 1.34 ...
Not a subscriber? Request 30 days free access to exclusive, behind-the-scenes reporting on defense policy and procurement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results